International Glaucoma Surgical Registry and Elios Vision announce partnership

Article

The open-access tool is the official registry partner of the European Glaucoma Society.

A screen shows a web of file folders, representing data on a digital server. Image credit: ©thodonal – stock.adobe.com

Currently, the IGSR holds data for thousands of procedures across 63 countries. Image credit: ©thodonal – stock.adobe.com

Medical device company Elios Vision, a pioneer in the glaucoma space, announced a partnership with the International Glaucoma Surgical Registry (IGSR). The open-access database is intended to promote information sharing from surgeons worldwide. In a press release, leaders from Elios Vision and the IGSR stated the new collaboration would foster support of, and broader use of, the database.1

“We are delighted to collaborate with and support the objectives of the International Glaucoma Surgical Registry,” said Dr Cameron Hudson, senior vice president OUS of Elios Vision.1 “Capturing long-term, real-world evidence is of high importance especially when adopting and integrating new surgical treatments. We hope the collaboration will encourage other surgeons to utilize the platform for audit and data generation purposes.”

Currently, the IGSR holds data for 7000 procedures across 63 countries. The registry, established over 5 years ago, became the official registry partner of the European Glaucoma Society (EGS) in 2019. Professor Keith Barton, co-founder of the IGSR with Dr Nathan Kerr, also participated in the joint statement.

“We are grateful for the support of Elios Vision in furthering the objectives of the International Glaucoma Surgical Registry and look forward to expanding the capabilities of the Registry through their support,” Barton said.1


Reference

1. Elios Vision Announces Collaboration with the International Glaucoma Surgical Registry. News release. Elios Vision, Inc., July 4, 2023. Accessed July 5, 2023.
Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.